TrialClinical rheumatology2022

Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials.

Alan J Kivitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.